⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Strides Pharma Science Limited and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Strides Pharma Science Limited
↗Bengaluru, India
Strides Pharma Science Limited is a global pharmaceutical company headquartered in Bengaluru, India, focused on the development and manufacturing of niche finished dosage formulations. The company operates a significant global footprint with manufacturing facilities across multiple continents, specializing in complex generics, soft gelatin capsules, and injectables.
Strides has a strong presence in regulated markets including the United States, Europe, and Australia, as well as emerging markets. The company has undergone significant restructuring, including the demerger of its softgel segment and the formation of an integrated CDMO entity, OneSource Speciality Pharma Limited, to streamline operations and focus on high-growth pharmaceutical segments.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$500M-$700M
Founded:1990
Ownership:public
Status:operating
STOCK
Exchange:NSE, BSE
Ticker:STRIDES
Market Cap:$1.15B
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Soft gelatin capsules, Injectables
Trial Phases:-
FDA Approvals:215
CORPORATE STRUCTURE
Subsidiaries:OneSource Speciality Pharma Limited
Key Partnerships:Clinton Foundation, UNICEF, World Bank
COMPETITION
Position:Challenger
LEADERSHIP
Key Executives:
Arun Kumar - Founder and Chairman
LINKS
Website:strides.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Strides Pharma Science Limited. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.